Beijing Tongrentang Co., Ltd (SHA:600085)
25.82
-0.31 (-1.19%)
May 20, 2026, 11:29 AM CST
Beijing Tongrentang Revenue
Beijing Tongrentang had revenue of 4.66B CNY in the quarter ending March 31, 2026, a decrease of -11.59%. This brings the company's revenue in the last twelve months to 16.64B, down -10.54% year-over-year. In the year 2025, Beijing Tongrentang had annual revenue of 17.26B, down -7.21%.
Revenue (ttm)
16.64B
Revenue Growth
-10.54%
P/S Ratio
2.15
Revenue / Employee
963.00K
Employees
17,284
Market Cap
35.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.26B | -1.34B | -7.21% |
| Dec 31, 2024 | 18.60B | 736.39M | 4.12% |
| Dec 31, 2023 | 17.86B | 2.49B | 16.19% |
| Dec 31, 2022 | 15.37B | 769.32M | 5.27% |
| Dec 31, 2021 | 14.60B | 1.78B | 13.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 44.06B |
| China Resources Sanjiu Medical & Pharmaceutical | 32.88B |
| Humanwell Healthcare (Group) | 23.93B |
| Livzon Pharmaceutical Group | 11.71B |
| Changchun High-Tech Industry (Group) | 11.67B |
| Shijiazhuang Yiling Pharmaceutical | 7.91B |
| Dong-E-E-Jiao | 6.80B |
| Hubei Jumpcan Pharmaceutical | 5.90B |